Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07479394 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of AHCC® Supplementation for Prevention of Respiratory Tract Infections Among Children Age 4-6 Years Old

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jun 1, 2026 to Aug 15, 2026v2 Show 5 more changesShow less
    • Primary and study completion pushed from Dec 31, 2026 to Feb 28, 2027
    • Eligibility criteria revised
    • Study description expanded, about 40 words
    • Collaborators expanded, about 6 words
    • Study title revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a study to evaluate the effects of a prebiotic, AHCC, a standardized extract of cultured Lentinula edodes mycelia, on immunologic markers and the incidence of respiratory tract infections in children.
Trial Details
NCT Number NCT07479394
Lead Sponsor Hasanuddin University
Collaborators: Amino Up Co. Ltd., Sapporo, Japan
Conditions
(from sponsor)		 Respiratory Tract Infections (RTI)
Related terms Respiratory Tract Infections
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov